Articles tagged "Pediatric"

2019 American Transplant Congress
Prevalence of Overweight and Obesity in Children after Kidney Transplantation. Risk Factors and Outcomes
M. L. Monteverde¹, J. M. Velasco¹, M. E. Izzo², M. Mannarino², J. P. Ibanez¹, A. B. Chaparro¹, C. E. Vezzani¹
¹Nephrology, Hospital de Pediatria JP Garrahan, Buenos Aires, Argentina, ²Food and Nutrition, Hospital de Pediatria JP Garrahan, Buenos Aires, Argentina
*Purpose: 1) To describe prevalence of overweight and obesity and changes in body mass index (BMI) and height Z-score at transplant time (T0) and 12…
2019 American Transplant Congress
500 Pediatric Liver Transplants At A Freestanding Pediatric Hospital – Where It Is Done Best
A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss
Baylor College of Medicine, Houston, TX
*Purpose: Our institution, a freestanding pediatric hospital (FPH) has a large pediatric liver transplant (LT) experience. Our aim was to analyze our experience with other…
2019 American Transplant Congress
Pediatric Liver Transplantation for Metabolic Disorders without Intrinsic Liver Disease: A 25 Year Experience
P. Vuong, L. Lee, N. Mineyev, S. Conlon, R. Shetty, W. Concepcion, C. A. Bonham, A. Gallo, T. Pham, S. Busque, M. L. Melcher, G. M. Enns, C. O. Esquivel
Stanford University Medical Center, Palo Alto, CA
*Purpose: Liver transplantation (LT) for acute and chronic end-stage-liver-disease is a well-accepted therapy in pediatrics. However, for children with metabolic disorders (MD) without intrinsic liver…
2019 American Transplant Congress
NK Cells Are Associated with Alloimmune Failure in Transplanted Children
E. T. Chambers¹, O. Martinez², M. Robien³, C. Chan¹, R. Ettenger⁴, P. Grimm⁵, H. Lee¹, E. Reed⁴, L. Stempora⁶, M. Sarwal⁷, B. Warshaw⁸, C. Zhao¹, A. D. Kirk⁶
¹Pediatrics, Duke University, Durham, NC, ²Surgery, Stanford, Palo Alto, CA, ³NIH, Bethesda, MD, ⁴Pediatrics, UCLA, Los Angeles, CA, ⁵Pediatrics, Stanford, Stanford, CA, ⁶Surgery, Duke University, Durham, NC, ⁷Pediatrics, UCSF, San Francisco, CA, ⁸Pediatrics, Emory University, Atlanta, GA
*Purpose: Alloimmune failure, defined as the development of donor specific antibody (DSA) and/ or allograft rejection, remains a significant complication in pediatric kidney transplantation. NK…
2019 American Transplant Congress
Factors Associated with Subclinical Cardiovascular Damage after Pediatric Liver Transplantation: A Longitudinal Observational Study
N. Memaran¹, I. Goldschmidt¹, B. Borchert¹, R. I. Sugianto¹, H. Wilke¹, R. Blöte¹, U. Baumann¹, E. Bauer¹, A. von Wick¹, N. Junge¹, C. Leiskau¹, E. D. Pfister¹, N. Richter², B. M. Schmidt³, A. Melk¹
¹Department of Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany, ²Department of General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany, ³Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
*Purpose: Cardiovascular (CV) events account for 8-13% of deaths after liver transplantation (LT) in adulthood. While CV risk factors are present in children after LT…
2019 American Transplant Congress
Management of Orphan Ducts After Pediatric Living Donor Liver Transplantation
N. Celik¹, A. Ganoza², A. Khanna², G. Bond², K. Soltys², R. Sindhi², J. Crowley³, A. Humar¹, G. Mazariegos²
¹Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, ²Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ³Department of Radiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
*Purpose: Living donor (LDLT) and split (SLT) livers are two technical variants of standard liver transplants that potentially increase the number of liver allografts available…
2019 American Transplant Congress
Cytokine Profiles in Children after Pediatric Kidney Transplantation with Acute Cellular Compared to Chronic Active Antibody-Mediated Rejection
N. Borsum, T. Ahlenstiel-Grunow, L. Pape
Pediatric Nephrology, Hannover Medical School, Hannover, Germany
*Purpose: Until now, no blood biomarkers have been identified to enable early diagnosis of acute cellular or chronic active antibody-mediated rejection (cABMR) after pediatric kidney…
2019 American Transplant Congress
Living Donor vs. Deceased Donor Liver Transplantation for Pediatric Patients with Metabolic Liver Disease
G. Gu, Q. Xia
Renji Hospital, Shanghai, China
*Purpose: Liver transplantation has been accepted as the appropriate treatment option for pediatric metabolic liver disease and the most common methods used are LDLT and…
2019 American Transplant Congress
The High Burden of Vaccine Preventable Infections Following Pediatric Solid Organ Transplant
A. G. Feldman¹, B. L. Beaty², D. Curtis³, E. Juarez-Colunga², A. Kempe⁴
¹Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado, Aurora, CO, ²University of Colorado, Aurora, CO, ³Pediatric Infectious Diseases, University of Colorado, Aurora, CO, ⁴Pediatrics, University of Colorado, Aurora, CO
*Purpose: Pediatric transplant recipients are at risk for vaccine preventable infections due to immunosuppression, suboptimal response to vaccines before and after transplant, and potential under-immunization…
2019 American Transplant Congress
Early Outcomes Comparing Two Steroid-Avoidance Protocols in Pediatric Renal Transplantation
D. Puliyanda¹, H. Pizzo¹, N. Rodig², M. Somers²
¹Cedars-Sinai Med Ctr, Los Angeles, CA, ²Pediatric Nephrology, Boston Childrens Hospital, Boston, MA
*Purpose: Steroid-avoidance in pediatric kidney transplants (txs) was found effective and safe with daclizumab induction. Upon daclizumab’s discontinuation, lymphocyte-depleting agents became used in this setting,…